Science Medicine Industry: Proposed to repurchase up to 1% of the total number of issued shares of the company.

Koji Pharmaceuticals announced on the Hong Kong Stock Exchange that the company's board of directors has approved a share repurchase plan. Starting from May 8, 2025, for 150 trading days in Hong Kong, the company will repurchase a maximum of 1% of the total issued shares on the open market, based on the share repurchase authorization of 2024 and the authorization approved by the company's shareholders at the annual general meeting scheduled for May 22, 2025.